Full trading conditions >>
|Product Type: Stock CFD|
|Sector: Healthcare||Industry: Drug Manufacturers - Specialty & Generic|
|Country: UK||Currency: USD|
|Trading Hours: 01:31-03:59, 05:01-07:59||Measurement Unit: Shares|
GW Pharmaceuticals is a biopharmaceutical company based in Britain. It produced the first cannabis derivative product to be accepted by the market: Sativex, which treats multiple sclerosis. In 2018, GW Pharmaceuticals’ other cannabis derivative product, Epidolex, was approved for treating epilepsy.